Arrowhead Pharmaceuticals Inc

General ticker "ARWR" information:

  • Sector: Health Care
  • Industry: Biotechnology
  • Capitalization: $2.8B

Arrowhead Pharmaceuticals Inc does not follow the US Stock Market performance with the rate: -22.8%.

Estimated limits based on current volatility of 2.1%: low 19.47$, high 20.32$

Factors to consider:

  • Price in estimated range

Stock Forecast*

* forecast is subjective and experimental, should not be used for any investment decisions

Long term estimates were made for the period from 2024-09-30 to 2026-09-30

  • 2024-09-30 to 2025-09-30 estimated range: [14.77$, 32.16$]
  • 2025-09-30 to 2026-09-30 estimated range: [12.73$, 27.83$]

Similar symbols

Short-term ARWR quotes

Long-term ARWR plot with estimates

Financial data

YTD 2022-09-30 2023-09-30 2024-09-30
Operating Revenue $243.23MM $240.74MM $3.55MM
Operating Expenses $421.74MM $445.74MM $604.63MM
Operating Income $-178.51MM $-205.00MM $-601.08MM
Non-Operating Income $5.80MM $-1.49MM $-11.38MM
Interest Expense $5.03MM $18.33MM $32.35MM
R&D Expense $297.31MM $353.19MM $505.87MM
Income(Loss) $-172.71MM $-206.49MM $-612.46MM
Taxes $3.79MM $2.78MM $-12.97MM
Profit(Loss) $-176.49MM $-209.28MM $-599.49MM
Stockholders Equity $105.96MM $271.34MM $185.44MM
Inventory $21.61MM $0.00MM $0.00MM
Assets $691.94MM $765.55MM $1,139.80MM
Operating Cash Flow $-136.13MM $-153.89MM $-462.85MM
Capital expenditure $52.78MM $176.74MM $141.47MM
Investing Cash Flow $-5.42MM $-96.16MM $-420.07MM
Financing Cash Flow $65.19MM $253.05MM $870.52MM
Earnings Per Share* $-1.67 $-1.91 $-5.00

* EPS are Split Adjusted, recent splits may be reflected with a delay.